Eton Pharmaceuticals (ETON) Operating Expenses (2018 - 2026)

Eton Pharmaceuticals has disclosed Operating Expenses across 9 years of filings, most recently posting $12.6 million for Q2 2026.

• In Q2 2026, Operating Expenses fell 5.82% year-over-year to $12.6 million; the TTM figure through Jun 2026 stood at $45.9 million (up 29.69% YoY), while the FY2025 annual figure was $43.6 million, up 67.58% from the prior year.
• Operating Expenses came in at $12.6 million for Q2 2026 at Eton Pharmaceuticals, up from $10.6 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $13.4 million in Q2 2025 to a low of $4.9 million in Q3 2022.
• Average Operating Expenses over 5 years is $7.5 million, with a median of $5.9 million recorded in 2023.
• Year-over-year, Operating Expenses fell 17.68% in 2022 and soared 81.91% in 2025.
• Over 5 years, Operating Expenses stood at $5.3 million in 2022, then advanced by 6.13% to $5.6 million in 2023, then climbed by 3.98% to $5.8 million in 2024, then soared by 81.91% to $10.6 million in 2025, then increased by 18.64% to $12.6 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $12.6 million in Q2 2026, $10.6 million in Q4 2025, and $9.2 million in Q3 2025.